| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President and CEO
1 company
Francisco D. Salva is President and CEO at AZTR. Francisco D. Salva's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $3.6M at current prices.
Net of sales, the AZTR filings show accumulation of 333,300 shares.
Francisco D. Salva has 11 Form 4 filings on record from December 2020 to June 2026, across 2 companies: President and CEO at Azitra (AZTR), 2023–2026; Director at Vincerx Pharma (VINC), 2020–2024.
The 13 reported transactions were 7 option or other derivative awards, 4 open-market purchases, 1 conversion and 1 stock award.
Counted by filing, the open-market trades come to 1 purchase worth about $100K and no sales.
The only open-market purchase was 333,300 shares of AZTR at an average $0.30 on February 13, 2024, about $100K. Twelve months later AZTR was down 99%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 13, 2024 | AZTR Azitra, Inc. | President and CEO | Buy | 333,300 | $0.30 | $99,990.00 | +6,666% | -78.4% | -98.8% |